Treatment.com AI and Novus Health Partnership Expands Access to its Global Library of Medicine (GLM)
Treatment.com AI has signed a Collaborative Agreement with Novus Health to utilize its Global Library of Medicine (GLM) for enhancing Novus Health's Health Risk Assessment programs. Novus Health, serving over 1.5 million members, will leverage Treatment's AI-driven GLM to improve healthcare navigation and patient outcomes. This partnership aims to explore Health Risk Assessment and Medical Second Opinion opportunities, as well as develop new joint commercial applications. The collaboration intends to foster the development, validation, and commercialization of innovative solutions to improve healthcare efficiency and patient care outcomes.
- Signed a Collaborative Agreement with Novus Health, a leader in health navigation.
- Partnership with an established company serving over 1.5 million members.
- Utilization of proprietary AI-driven Global Library of Medicine (GLM).
- Potential to enhance Health Risk Assessment programs.
- Opportunities for developing new joint commercial applications.
- Promotes the development, installation, and commercialization of new healthcare solutions.
- Aims to improve healthcare efficiency and patient outcomes.
- Possibility of augmenting services with unparalleled efficiency and accuracy.
- No immediate financial impact or revenue projections mentioned.
- Success depends on the implementation and testing of new solutions.
- Potential risks in market adoption and commercialization of new tools.
VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with Health Care Services International Inc (o/a Novus Health). (“Novus Health”) to explore utilization of Treatment’s proprietary Global Library of Medicine (“GLM”) to further enhance Novus Health’s Health Risk Assessment programs.
Treatment is partnering with Novus Health, an acknowledged leader in health navigation supporting over 1.5 million members and their families. Over the past 7 years and in collaboration with hundreds of global healthcare professionals, utilizing our proprietary algorithms, Treatment has built one of the world’s most intelligent, personalized healthcare AI engines, the Global Library of Medicine (GLM). Working with a number of leading North American Health Insurers, Novus Health has built a trusted navigation platform that simplifies health care experiences by bringing together everything an individual needs to successfully manage their care journey.
Treatment and Novus Health also intend to explore mutually beneficial opportunities through the partnership, this will include Health Risk Assessment and Medical Second Opinion.
The collaboration also allows Novus Health and Treatment to work closely on testing and development of further new mutual joint commercial applications and/or solutions. The intent of this collaboration is to promote the development, installation, testing, validation, and commercialization of one or more novel solutions that further the goals of both companies and proactively impact the health insurance market.
Dr. Essam Hamza, CEO of Treatment, comments: “We are very excited to partner with a recognized leading healthcare firm in Novus Health. There is a near term opportunity to implement our proprietary AI diagnostic tools into the solutions offered to their vast customer base. However, with this collaboration we also have an opportunity to extend into new mutually developed tools and solutions that have the ability to further improve health care efficiency and patient outcomes.”
Jamie Marcellus, CEO of Novus Health, comments: "We are excited about the potential for Treatment.com’s AI to augment our services. Their platform offers the possibility of unparalleled efficiency and accuracy in health risk assessments, drawing insights from vast data sets to detect patterns and predict potential risks. By leveraging these tools, our members can make better informed decisions swiftly, enhancing care and enabling proactive interventions to mitigate health threats effectively.”
About Treatment.com AI Inc.
Treatment.com AI is a company utilizing AI to positively disrupt the healthcare sector and impact current inefficiencies and challenges. Over the past 7+ years and with the input of hundreds of healthcare professionals globally, Treatment.com AI has built the world’s most intelligent, personalized healthcare AI engine, the Global Library of Medicine (GLM). Providing the highest qualified clinical information and support to all healthcare professionals, the GLM delivers >
About Novus Health
Novus Health connects people with care and is a leader in health navigation. We deliver personalized support, reputable information, and health-related services in one single destination, using technology to help individuals make informed health decisions. In doing so, we create value for our partners while improving their members’ and customers’ health and well-being. To learn more, visit www.novushealth.com
Contact: Jamie Marcellus, CEO jmarcellus@novushealth.com
If you would like to find out more about Novus Health’s products and services, please email at info@novushealth.com
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO
If you would like to find out more about Treatment’s products and services, please email at info@treatment.com
For media inquiries, contact: media@treatment.com
Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955
Cautionary Statements
This news release contains forward-looking statements that are based on Treatment.com AI’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although Treatment.com believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Treatment.com undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
FAQ
What is the significance of the partnership between Treatment.com AI and Novus Health?
How many members does Novus Health support?
What is the potential benefit of Treatment.com's GLM in healthcare?
What are the key objectives of the collaboration between Treatment.com AI and Novus Health?
What stock symbols are associated with Treatment.com AI?
